Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Des mains de chercheuse qui manipulent

Major cross-functional projects

Last update: 20/11/2024 Reading time: 1min

In 2024, Paris Brain Institute launched the ambitious initiative of major cross-functional, interdisciplinary and collaborative research programs.
 

Major cross-functional projects aim to make transformative contributions in their respective fields and to foster synergistic collaborations within the Institute and at the international level. The teams of Paris Brain Institute seek to build bridges between different disciplines, different approaches, and within a broad panel of neurodegenerative pathologies. The objective of this profoundly interdisciplinary approach is to create new fields of exploration at the interfaces, to allow the emergence of new ideas and hypotheses at the borders of current knowledge, by questioning current challenges in new ways. Some of these projects are conducted with international centres of research excellence, which represents a strategic approach to broadening the overall scope of our research.
 

Purpose of Major Cross-functional Projects

Purpose of Major cross-functional projects

The ultimate aim of these cross-functional  programmes is to open up concrete prospects by speeding up translational and clinical research into new treatments and solutions for the pathologies of the brain, with the idea of positively impacting the lives of nearly a billion patients worldwide by aiming at the prevention, repair or mitigation of the challenges posed by the pathologies of the brain.

The four Major cross-functional projects

The four Major cross-functional projects

  • Major cross-functional  project NEUROPREMS (project leaders: Alexandra Durr, Jean-Christophe Corvol) - Neurodegenerative and inflammatory markers in pre-symptomatic neurodegenerative diseases.
  • Major cross-functional  project Deep Brain Stimulation (DBS) (Project Leader Claire Wyart) - An approach to motor circuits linking genes to behaviour in Parkinson's disease. To learn more about the big DBS transversal project.
  • Major Cross-functional Project NEIMO (Project Leaders Jean-Léon Thomas, Stéphanie Lenck) - Neuroinflammation Surveillance, a collaborative initiative between Paris Brain Institute and Yale University (US).
  • Major Cross-functional project Brain Functional Genome Program (BFGP) (Project Leader: Bassem Hassan) - From Genomic Variation to Clinical Diagnosis: The Human Functional Genome Project.

News that might interest you

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news